{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:50:08Z","timestamp":1761310208235},"reference-count":35,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2004,12,13]],"date-time":"2004-12-13T00:00:00Z","timestamp":1102896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Xenotransplantation"],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold><jats:bold> Background:\u2002<\/jats:bold> In pig\u2010to\u2010nonhuman primate solid organ xenotransplantation using organs from donors transgenic for human decay\u2010accelerating factor (hDAF), the main type of rejection is antibody\u2010mediated (acute humoral xenograft rejection, AHXR). This occurs despite the complement\u2010regulatory function of the transgene, neutralization of natural antibodies to Gal<jats:italic>\u03b1<\/jats:italic>1\u20133Gal (Gal) using soluble glycoconjugates, and chronic immunosuppression. As complement components play a major role in graft destruction after antibody binding, we evaluated the efficacy of chronic complement inhibition by soluble complement receptor type 1 (TP10).<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Life\u2010supporting hDAF\u2010transgenic kidney transplantation was performed in cynomolgus monkeys, using cyclophosphamide induction, and maintenance immunosuppression with cyclosporin A, mycophenolate sodium, and tapering steroids. Rejection was treated with bolus steroid injections: if not successful animals were terminated. Three groups were studied: in group 1 (n\u2003=\u20034) GAS914 (a soluble glycoconjugate comprising Gal on a poly\u2010L\u2010lysine backbone) was added before and after transplantation; group 2 (n\u2003=\u20032) received GAS914 as in group 1 and in addition TP10 before and after transplantation; in group 3 (n\u2003=\u20034) GAS914 was only given before transplantation and TP10 as in group 2. Monitoring included the regular assessment of anti\u2010porcine antibodies, complement activity (soluble C5b\u20109), therapeutic drug monitoring, and graft histology.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Survival in group 1 was 6, 12, 31 and 37\u2003days, respectively, and in all four cases graft histology showed AHXR. The two animals in groups 2 survived 3 and 15\u2003days, respectively, and similarly showed AHXR in graft histology. In group 3 two animals showed AHXR (10 and 37\u2003days survival, respectively), and two others did not show AHXR (20 and 32\u2003days survival, respectively). The diagnosis AHXR included the deposition of complement activation products in the graft, which were present at lower intensity in animals treated with TP10. In all animals GAS914 effectively neutralized circulating anti\u2010Gal antibody. Antibodies were detectable in the circulation of all animals using porcine erythrocytes in a hemolytic assay, although at lower levels than before transplantation. Soluble C5b\u20109 was not detectable in the circulation of animals receiving TP10, and circulating TP10 concentrations in these animals were in a presumed pharmacologically active range.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> The inclusion of TP10 in the immunosuppressive protocol does not clearly lead to improved xenograft survival. Despite effective neutralization of anti\u2010Gal antibodies and effective inhibition of systemic complement activity, AHXR was apparent in four of six animals under chronic TP10 treatment, including deposits of complement activation products in the graft. Apparently, effective systemic complement inhibition by TP10 in combination with local complement regulation by the hDAF transgene product does not necessarily result in effective inhibition of complement activation at locations in the xenograft upon binding of anti\u2010porcine antibodies to the grafted endothelium.<\/jats:p>","DOI":"10.1111\/j.1399-3089.2004.00184.x","type":"journal-article","created":{"date-parts":[[2004,12,13]],"date-time":"2004-12-13T14:27:38Z","timestamp":1102948058000},"page":"20-29","source":"Crossref","is-referenced-by-count":23,"title":["The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF\u2010transgenic pig\u2010to\u2010primate life\u2010supporting kidney xenografts"],"prefix":"10.1111","volume":"12","author":[{"given":"Tuan T.","family":"Lam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Hausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie","family":"Hook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Macy","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Christians","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Baluom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Duthaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Katopodis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilda","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk\u2010Jan","family":"Schuurman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Borie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall E.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,12,13]]},"reference":[{"key":"e_1_2_14_2_2","first-page":"15","article-title":"Long\u2010term survival of nonhuman primates receiving life\u2010supporting transgenic porcine kidney grafts","volume":"70","author":"Cozzi E","year":"2000","journal-title":"Transplantation"},{"key":"e_1_2_14_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200101150-00021"},{"key":"e_1_2_14_4_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3089.1999.00017.x"},{"key":"e_1_2_14_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200112270-00006"},{"key":"e_1_2_14_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200006270-00008"},{"key":"e_1_2_14_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200204150-00024"},{"key":"e_1_2_14_8_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3089.2000.00068.x"},{"key":"e_1_2_14_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200201150-00024"},{"key":"e_1_2_14_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1399-3089.2003.00096.x"},{"key":"e_1_2_14_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200206150-00014"},{"key":"e_1_2_14_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI16526"},{"key":"e_1_2_14_13_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1078942"},{"key":"e_1_2_14_14_2","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1073\/pnas.0307819101","article-title":"Production of \u03b1\u20101,3\u2010galactosyltransferase null pigs via nuclear transfer with fibroblasts bearing loss of heterozygosity mutations","volume":"1001","author":"Kolber\u2010Simonds D","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_2_14_15_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3089.2003.02092.x"},{"key":"e_1_2_14_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3089.2004.00173.x"},{"key":"e_1_2_14_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200203270-00009"},{"key":"e_1_2_14_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1991.tb06206.x"},{"key":"e_1_2_14_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0995-967"},{"key":"e_1_2_14_20_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3089.2002.1o042.x"},{"key":"e_1_2_14_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200203150-00006"},{"key":"e_1_2_14_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199912150-00007"},{"key":"e_1_2_14_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000064335.50622.20"},{"key":"e_1_2_14_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00353.x"},{"key":"e_1_2_14_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199711150-00005"},{"key":"e_1_2_14_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199703270-00017"},{"key":"e_1_2_14_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199610150-00022"},{"key":"e_1_2_14_28_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3089.2003.01102.x"},{"key":"e_1_2_14_29_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3089.2002.1o056.x"},{"key":"e_1_2_14_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3089.2004.00139.x"},{"key":"e_1_2_14_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(02)02925-1"},{"key":"e_1_2_14_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200301150-00003"},{"key":"e_1_2_14_33_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3089.2003.02014.x"},{"key":"e_1_2_14_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3089.2004.00048.x"},{"key":"e_1_2_14_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780086"},{"key":"e_1_2_14_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199505000-00018"}],"container-title":["Xenotransplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3089.2004.00184.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3089.2004.00184.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T23:53:06Z","timestamp":1696895586000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3089.2004.00184.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,13]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1111\/j.1399-3089.2004.00184.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3089.2004.00184.x","archive":["Portico"],"relation":{},"ISSN":["0908-665X","1399-3089"],"issn-type":[{"value":"0908-665X","type":"print"},{"value":"1399-3089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,13]]}}}